28th Jun 2006 17:39
Cyprotex PLC28 June 2006 Press release 28 June 2006 Cyprotex PLC Director's Dealings Cyprotex PLC (AIM: CRX), the provider of pharmacokinetic technology andinformation, today announces that Mr Nikolas Sofronis, a non-executive Directorof the Company, bought on Tuesday 27 June 2006 40,000 ordinary shares of 0.1peach in the capital of the Company at a price of 7.11p per share. As a consequence of this purchase, the total number of shares of Cyprotex heldby Mr Sofroni represents less than 0.1% of the issued share capital. - Ends - For further information:Cyprotex PLCRobert Morrisson Atwater Tel: 016 2550 [email protected] www.cyprotex.comCode Securities LimitedRichard Potts Tel: 020 7776 [email protected] www.codesecurities.com Media enquiries:AbchurchHeather Salmond / Georgina Bonham Tel: 020 7398 [email protected] www.abchurch-group.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
CRX.L